Error
Jump to navigation
Jump to search
Pages in category "News"
The following 72 pages are in this category, out of 184 total.
(previous page) (next page)R
- Rhythm control is no better than rate control among patients with atrial fibrillation and congestive heart failure
- Rimonabant does not reduce atherosclerosis progression in STRADIVARIUS
- RNAPc2 in ACS, Results of ANTHEM-TIMI 32. June 22, 2007
- Rosiglitazone: Twists and Turns on the Road to Clarity Regarding Safety with Rosiglitazone. August 10, 2007
- Rosuvastatin is Not Beneficial Among Patients with Chronic Heart Failure: Results from GISSI-HF trial
- Rosuvastatin reduces coronary artery disease progression over time in the ASTEROID trial
S
- Should beta-Blockers Be Continued for Patients Hospitalized with decompenstated Heart Failure
- Similar nephrotoxic effects with iodixanol and iomeprol in the CONTRAST trial
- Simvastatin and ezetimibe combination does not reduce the rate of progression of aortic valve disease in the SEAS trial
- SPECT Substudy of COURAGE shows Improved Perfusion with PCI at Follow-Up
- Standard Physician Care for Heart Failure is Just as Effective as and Less Expensive Than a Home Monitoring System
- States and Institutions Impose Restrictions on Physician-Industry Relationships
- Statins found to be protective against recurrence of atrial fibrillation after cardioversion
- Statins in Heart Failure: Results of CORONA
- Statins may cause sleep disorders
- Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales
- Special:Badtitle/NS100:Study demonstrates that non-cardiac cells can help repair a damaged heart; new excitement for existence of cardiac stem cells. August 26, 2007
- Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients
- Study proposes a final common pathway linking smoking, kidney disease, and inflammation to atherogenesis
- Subendocardial Ischemia In Patients with Chest Pain and Normal Coronary Angiograms: A Cardiovascular Magnetic Resonance Study
- Successful PCI for Chronic Total Occlusion of the LAD is Associated with Improved Long-term Survival
- Sunitinib, a small molecular weight tyrosine-kinase inhibitor, is found to have cardiac toxicity
- Susceptibility loci for intracranial aneurysm in European and Japanese populations
- SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease
T
- Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial
- The 2009 SCAI Annual Scientific Sessions is to be held in Las Vegas
- The ASTRAL Trial Demonstrates Angioplasty and Stenting Offer No Benefit Over Medical Therapy in Patients with Renal Arterial Stenoses
- The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin
- The Efficacy of XIENCE V Stent over Taxus Stent Decreases with Time: Results from the SPIRIT II study
- The EVEREST trial suggests MitraClip® for mitral regurgitation is effective
- The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
- The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
- The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction.
- The safety of thiazolidinediones in older diabetics
- Thrombus aspiration in patients with ST elevation myocardial infarction improves mortality at 1 year in the TAPAS trial
- Special:Badtitle/NS100:Thyroid abnormalities affect more than 30% of males on amiodarone
- Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study
- Time to Abandon Facilitated PCI: Results from the FINESSE trial
- Tirofiban and transfer compares favorably to fibrinolysis in STEMI
- Today In Medicine: European Heart Journal Announces Articles to be Available in Open Source Format
- Today in Medicine: Implanting the Same vs. Different Drug-Eluting Stent (DES) for the Treatment of DES Restenosis.
- Today in Medicine: Judges or Defendants: Should the Journals be the Judges on Conflict of Interest?
- Today in Medicine: Mixed Long-term Results for Sirolimus-Eluting Stent Implantation in Diabetic Patients
- Today in Medicine: NY Times Describes Health and Economic Impact of Ablation for A Fib
- Today in Medicine: SALT study questions prevalence of undiagnosed primary hyperaldosteronism among patients with low-renin hypertension
- Today in Medicine: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients
- Today in Medicine: Study Shows Favorable Long-Term Outcomes for DES Implantation in Unprotected Left-main Lesions
- Torcetrapib Associated with Higher CV Event Rates in ILLUMINATE
- TRANSCEND Study Misses Primary Endpoint
- TRANSCEND Study suggests that telmisartan reduces cardiovascular events
- Transfusion of blood stored for more than 14 days increases mortality among cardiac surgical patients
- Treatment of hypertension in the very old reduces all-cause mortality
- Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study
- Treatment of paroxysmal nocturnal hemoglobinuria with the anti-complement antibody eculizumab helps prevent thromboembolism
- TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis
U
- Understanding the stiff heart: scientists discover the cells and molecules responsible for cardiac fibrosis. August 12, 2007
- Underutilization of Cardiac Rehab Despite Guidelines and Reimbursement
- Upstream Pharmacotherapy not Superior to Cath Lab Based Therapy in Primary PCI: Results from the FINESSE Trial
- Use of Epoetin Alpha in Critically Ill Patients. Sept 10th, 2007.
- Use of Epoetin Alpha in Critically Ill Patients. Sept 8th, 2007.